-
- Apr 10/25
Neural stem cells outside the brain: Discovery opens new paths for regenerative medicine - Apr 9/25
Study reveals sex differences in bone regeneration - Apr 9/25
Placenta-derived signals improve liver organoid size and function - Apr 9/25
New gene editing tool shows promise for treating diseases with multiple mutations - Apr 9/25
Firm seeks Japan gov’t approval for iPS-derived heart muscle sheets - Apr 9/25
UBC opens purpose-built biomed engineering facility - Apr 9/25
Automation, AI and closed systems in cell and gene therapy production - Apr 9/25
Cystic fibrosis: is the next blockbuster a gene therapy? - Apr 9/25
High-throughput screening techniques to improve cellular drug discovery - Apr 9/25
Stem cell study uncovers shared genes for hearing and vision repair - Apr 9/25
Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division - Apr 8/25
Tracking tissue development to inspire regenerative therapies - Apr 8/25
The ISSCR welcomes new Vice President, Treasurer, Clerk and Directors - Apr 7/25
Toronto’s University Health Network aims to attract 100 scientists - Apr 7/25
Batten disease hits the gut, but gene therapy may help - Apr 7/25
Lexeo locks in pivotal trial plan as clinical data pump up prospects of cardiac gene therapy - Apr 7/25
Will tRNA therapy be the next big thing in genetic disease treatment? - Apr 7/25
A new approach to treating osteoarthritis - Apr 4/25
Novartis’ gene therapy shows promise for spinal muscular atrophy - Apr 4/25
CRISPR tool unveils genetic drivers of blood cell maturation - Apr 3/25
Gene therapies for rare diseases twice as likely to win FDA nod, study finds - Apr 3/25
Roche halts testing of Sarepta Duchenne gene therapy in Europe - Apr 3/25
Atsena closes $150m in Series C round to progress gene therapy - Apr 3/25
CAR-T cell therapy applications beyond blood cancer - Apr 3/25
UC Davis Health launches new cell therapy trial for chronic kidney disease patients - Apr 3/25
Revolutionary printed skin offers promising alternative to animal testing - Apr 2/25
New “smart” immune cells: A breakthrough for long-lasting tumour destruction - Apr 2/25
How is the cell and gene therapy landscape evolving? - Apr 2/25
The next decade of cell and gene therapies - Apr 1/25
Why is Philadelphia called the Cellicon Valley? - Apr 1/25
Comprehensive AAV delivery map aids in advancing gene therapy - Apr 1/25
Tackling autoimmune disease with cell and gene therapy - Apr 1/25
Gene silencing: a step forward for rare disease therapy - Apr 1/25
Scientists discover key genes for regenerating cells in the ear and eye - Mar 31/25
UCLA team developing one-time, inhalable CF gene-editing treatment - Mar 31/25
Cell, gene therapy makers lose a champion at FDA with exit of Peter Marks - Mar 31/25
Vertex abandons islet cell-device combo after failing to improve diabetes biomarker - Mar 31/25
Gene therapy reverses symptoms of rare neurological disease in animal models - Mar 31/25
Molecular ‘staples’ resolve puzzle of how collagen stays together - Mar 28/25
Bluebird gets rival takeout offer from Ayrmid - Mar 28/25
Peter Marks, FDA’s top vaccine regulator, forced out - Mar 27/25
New technology is poised to bring gene therapy to common chronic diseases - Mar 27/25
Gene editing with adeno-associated virus vector offers hope for hereditary deafness - Mar 27/25
Successful CAR-T cell therapy for end-stage multiple myeloma using advanced cellular product performed in Hong Kong - Mar 27/25
Beam Therapeutics reports gene editing breakthrough - Mar 27/25
Advancing gene therapy: How the industry is moving beyond the trough of disillusionment - Mar 27/25
Elusive stem cells discovered in human retina may lead to treatment for blindness - Mar 27/25
Correcting the mutation behind a genetic eye disease - Mar 26/25
New protein target identified for muscle repair and regeneration - Mar 26/25
Epicrispr banks $68M to test epigenetic editing on rare muscle disease - Mar 26/25
Real-world study suggests DMD gene therapy Is safe, effective - Mar 26/25
User-friendly software enables easy estimation of 3D gene expression distribution
- Apr 10/25
